title: [Effect of verapamil on electrophysiologic characteristics of the accessory pathway in patients with Wolff-Parkinson-White syndrome].
authors.forename: W
authors.initials: W
authors.lastname: Molenda
authors.forename: C
authors.initials: C
authors.lastname: Telichowski
authors.forename: J
authors.initials: J
authors.lastname: Góral
authors.forename: W
authors.initials: W
authors.lastname: Banasiak
authors.forename: E
authors.initials: E
authors.lastname: Metner
authors.forename: J
authors.initials: J
authors.lastname: Petruk
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014700:Verapamil / Q000627:therapeutic use*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D014700:Verapamil
vernacular_title: Wpływ werapamilu na elektrofizjologiczne właściwości drogi dodatkowej u chorych z zespołem Wolffa-Parkinsona-White'a.